Real-time enrollment status for this myeloproliferative neoplasms clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:40 AM UTC
| NCT Number | NCT07441694 |
| Recruiting Status | Recruiting |
| Condition | Myeloproliferative Neoplasms |
| Phase | Clinical Trial |
| Target Enrollment | 218 participants |
| Active Locations | 22 sites in the US |
| Sponsor | Incyte Corporation |
| Last Updated on CT.gov | May 29, 2026 (May 29, 2026) |
As of July 13, 2026: Clinical trial NCT07441694 is currently recruiting participants. This clinical trial study for myeloproliferative neoplasms is actively seeking new participants at 22 locations across the United States. The study is sponsored by Incyte Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07441694 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07441694 was last updated May 29, 2026 (May 29, 2026). HelloStudys verifies this status automatically.